Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor

Yoshida Soichiro; Takahara Taro; Arita Yuki; Ishii Chikako; Uchida Yusuke; Nakagawa Keiko; Toda Kazuma; Sakamoto Tsuyoshi; Kijima Toshiki; Yokoyama Minato; Ishioka Junichiro; Matsuoka Yoh; Saito Kazutaka; Yoshimura Ryoichi; Fujii Yasuhisa

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor

【24h】

Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor

机译：渐进式前列腺癌的渐进式场所导向治疗：渐进遗址的定位作为预后因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: Locoregional therapy for oligometastatic prostate cancer has generated great interest. However, its benefit for castration-resistant prostate cancer (CRPC) has not been fully demonstrated. Our objective was to evaluate the treatment outcome of progressive site-directed therapy (PSDT) for oligoprogressive CRPC (OP-CRPC).

机译：目的：用于寡粒子瘤前列腺癌的招生治疗产生了极大的兴趣。然而，它对抗阉割前列腺癌（CRPC）的效益尚未得到充分证明。我们的目的是评估脱霉菌CRPC（OP-CRPC）进行渐进式定向治疗（PSDT）的治疗结果。

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2019年第2期|共6页
作者
Yoshida Soichiro; Takahara Taro; Arita Yuki; Ishii Chikako; Uchida Yusuke; Nakagawa Keiko; Toda Kazuma; Sakamoto Tsuyoshi; Kijima Toshiki; Yokoyama Minato; Ishioka Junichiro; Matsuoka Yoh; Saito Kazutaka; Yoshimura Ryoichi; Fujii Yasuhisa;
展开▼
作者单位

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokai Univ Sch Engn Dept Biomed Engn Hiratsuka Kanagawa Japan;

Yaesu Clin Adv Imaging Ctr Dept Radiol Tokyo Japan;

Yaesu Clin Adv Imaging Ctr Dept Radiol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Radiat Therapeut &

Oncol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Radiat Therapeut &

Oncol Tokyo Japan;

PixSpace Ltd Fukuoka Fukuoka Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Radiat Therapeut &

Oncol Tokyo Japan;

Tokyo Med &

Dent Univ Dept Urol Tokyo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor [J] . Yoshida Soichiro, Takahara Taro, Arita Yuki, International Journal of Radiation Oncology, Biology, Physics . 2019,第2期

机译：渐进式前列腺癌的渐进式场所导向治疗：渐进遗址的定位作为预后因素
2. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. [J] . Scher HI, Jia X, de-Bono JS, The lancet oncology . 2009,第3期

机译：循环肿瘤细胞作为进行性去势抵抗性前列腺癌的预后标志物：IMMC38试验数据的重新分析。
3. Excellent Response to Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient With Progressive Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation After Lu-177-PSMA Therapy [J] . Liu Chen, Liu Teli, Zhang Jingjing, Clinical nuclear medicine . 2019,第11期

机译：对Lu-177-PSMA治疗后具有神经内分泌分化的患者患者患者的Lu-177-致乳酸肽受体放射性核素治疗的优异反应
4. Sequencing of Therapies in Men with Castration-Resistant Prostate Cancer [C] . Philip Kantoff Genitourinary Cancers Symposium . 2012

机译：抗阉割前列腺癌的男性疗法测序
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Abiraterone acetate plus LHRH therapy versus abiraterone acetate while sparing LHRH therapy in patients with progressive metastatic and chemotherapy-naïve castration-resistant prostate cancer (SPARE): study protocol for a randomized controlled trial [O] . Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, 2017

机译：醋酸阿比特龙联合LHRH治疗与醋酸阿比特龙同时保留LHRH治疗在进行性转移性和未接受去势的前列腺癌（SPARE）患者中的研究：一项随机对照试验的研究方案
7. Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer [O] . Keshan Wang, Hailong Ruan, Tianbo Xu, 2018

机译：抗阉割前列腺癌进展机制和治疗的最新进展

Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor

摘要

著录项

相似文献

相关主题

期刊订阅